University of North Carolina researchers have developed a combination treatment that shows remarkable promise against glioblastoma, an aggressive brain cancer…
LIXTE is advancing a first-in-class PP2A inhibitor platform designed to enhance, rather than replace, established chemotherapy and immunotherapy regimens. The…
A gene regulator best known for its role in bone development is now emerging as a potential lever to restore…
Al Jazeera is unveiling a new artificial intelligence platform aimed at supporting its teams as journalism becomes more data-heavy and…
Researchers have revealed a new blood test that can determine whether brain cancer therapies are being effective. The diagnostic tool could guide glioblastoma physicians on whether to maintain current drug…
Scientists at Northwestern Medicine have discovered a biological marker that predicts which cancer patients are more resistant to immunotherapy. Dubbed USP22, the…
The U.S. Navy has partnered with AI firm Palantir on a $448 million effort to advance computational intelligence and machine…
Administering chemotherapy at specific times could significantly improve outcomes for brain cancer patients. Washington University in St. Louis researchers discovered…
A new analysis is calling for major changes to how the United States screens for lung cancer. Current rules, the…
China's battery-car mastery is propelling its flying vehicle manufacturers ahead of global rivals. Expertise developed through years of electric vehicle…